Quality Assessment of Systematic Reviews of Health Economic
Evaluations: Pitfalls with the Application of the PRISMA Statement.
Comment on Quang et al. (Sys Rev Pharm. 2017;8(1):52-61)Miriam Luhnen, Siw Waffenschmidt, Anja Schwalm, Andreas Gerber-Grote, Gloria Hanke.
In a recently published article, Quang et al. evaluate the quality of systematic
reviews of health economic evaluations of interventions for hepatitis.1
As the authors of one of the systematic reviews included in the assessment,2
we would like to discuss the methods which were applied and which, in
our opinion, seem to be inappropriate.
Key words: Health economic evaluation, Systematic review, Quality assessment.